Alex Tarnava is a biomedical innovator, inventor, and researcher known for his work in molecular hydrogen therapy, cellular health, and emerging biohacking technologies. His work sits at the intersection of biomedical science, human performance, and health optimization, with a focus on developing practical tools that improve resilience, recovery, and overall well-being.

Alex is the inventor of the world’s only open-cup molecular hydrogen tablet, a patented delivery system that has become one of the most widely used and studied forms of hydrogen therapy. This technology has been utilized in more than 20 published clinical trials and has contributed to growing scientific interest in the therapeutic potential of molecular hydrogen for reducing oxidative stress, supporting mitochondrial function, and improving cellular health.

He has co-authored 17 peer-reviewed scientific papers, with additional research currently in press and under review, and his work is widely cited in the field of hydrogen therapy. Alex is also the co-inventor, alongside Dr. Tyler LeBaron, of Inhale H2, a hydrogen inhalation system developed over seven years and launched in 2025 to support safe and effective delivery of molecular hydrogen.

Recognized for his contributions to the field, Alex was invited by the Molecular Hydrogen Institute to serve as the first chairman of its Research Committee, where he helps guide research initiatives and future directions in hydrogen science.

In addition to his work in biotechnology, Alex serves as a strategic advisor to VeriFoods, a consumer platform designed to provide transparency around food quality by identifying contaminants such as pesticides, heavy metals, and microplastics. His broader work reflects a commitment to empowering individuals with better data and tools to make informed decisions about their health.

Alex is also the author of StressHacked: How to Get Stronger in a Civilization Designed to Break You, with his second book, The Stone Wall: On Power, Human Nature, and the Failures of Justice, scheduled for release in 2026.